Physician profile
Jennifer E Payne
NPI 1154640100
$1,138.44
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $567 · 2020: $162 · 2021: $387 · 2022: $22.37.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $197.90 | 2019-2021 | |
| Roche Diagnostics Corporation | $195.95 | 2019-2021 | |
| Abbvie INC. | $169.98 | 2019-2022 | |
| Aspira Women'S Health INC | $153.34 | 2021 | |
| Astellas Pharma US INC | $91.95 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $67.34 | 2019-2021 | |
| Exeltis, USA INC. | $56.79 | 2019-2020 | |
| Lupin INC. | $47.86 | 2019 | |
| Pfizer INC. | $29.12 | 2019 | |
| Applied Medical Resources Corporation | $22.51 | 2020 | |
| Boston Scientific Corporation | $20.98 | 2020 | |
| Mayne Pharma Commercial LLC | $16.58 | 2021 | |
| Axonics, INC. | $16.45 | 2021 | |
| Ethicon US, LLC | $14.27 | 2021 | |
| Duchesnay USA Incorporated | $13.07 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $12.51 | 2019 | |
| Coopersurgical, INC. | $11.84 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Payne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.